{"entity":{"type":"insider","cik":"0001360463","url":"/insider/0001360463","json_url":"/insider/0001360463.json","name":"Dillaha Larry","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":8,"first":"2007-02-23","last":"2014-03-06","span_basis":"filed_date"},"name_variants":[{"name":"Dillaha Larry","source":"filing","n_filings":8,"first_seen":"2007-02-23","last_seen":"2014-03-06"}],"transactions":[{"id":6201080,"accession":"0001209191-14-018066","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001209191-14-018066","line_url":"/filing/0001209191-14-018066","is_derivative":false,"issuer_cik":"0001360463","issuer_name":"Insys Therapeutics, Inc.","issuer_ticker":"INSY","issuer_name_source":null,"issuer_url":"/issuer/0001360463","owner_cik":"0001360463","owner_name":"Dillaha Larry","owner_display_name":"Dillaha Larry","owner_url":"/insider/0001360463","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":149932.0,"shares_display":"149,932","price_per_share":74.56555231705039,"price_display":"74.57","price_state":"stated","total_value":11179762.39,"total_display":"11,179,762.39","total_whole":"11,179,762","shares_owned_after":55268.0,"shares_owned_after_display":"55,268","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-05","filed_date":"2014-03-06","scope":"insider","n_lines":10},{"id":2469448,"accession":"0001104659-08-052234","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-08-052234","line_url":"/filing/0001104659-08-052234#line-1","is_derivative":false,"issuer_cik":"0001106773","issuer_name":"SCIELE PHARMA, INC.","issuer_ticker":"SCRX","issuer_name_source":null,"issuer_url":"/issuer/0001106773","owner_cik":"0001360463","owner_name":"Dillaha Larry","owner_display_name":"Dillaha Larry","owner_url":"/insider/0001360463","role":"Officer (EVP and Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Medical Officer","security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":875.0,"shares_display":"875","price_per_share":20.336,"price_display":"20.34","price_state":"stated","total_value":17794.0,"total_display":"17,794.00","total_whole":"17,794","shares_owned_after":74511.0,"shares_owned_after_display":"74,511","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-11","filed_date":"2008-08-12","scope":"insider"},{"id":3901225,"accession":"0001104659-08-027349","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-08-027349","line_url":"/filing/0001104659-08-027349#line-1","is_derivative":false,"issuer_cik":"0001106773","issuer_name":"SCIELE PHARMA, INC.","issuer_ticker":"SCRX","issuer_name_source":null,"issuer_url":"/issuer/0001106773","owner_cik":"0001360463","owner_name":"Dillaha Larry","owner_display_name":"Dillaha Larry","owner_url":"/insider/0001360463","role":"Officer (EVP and Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Medical Officer","security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":350.0,"shares_display":"350","price_per_share":19.35,"price_display":"19.35","price_state":"stated","total_value":6772.5,"total_display":"6,772.50","total_whole":"6,773","shares_owned_after":75386.0,"shares_owned_after_display":"75,386","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-04-25","filed_date":"2008-04-28","scope":"insider"},{"id":3741913,"accession":"0001104659-08-012372","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-08-012372","line_url":"/filing/0001104659-08-012372#line-1","is_derivative":false,"issuer_cik":"0001106773","issuer_name":"SCIELE PHARMA, INC.","issuer_ticker":"SCRX","issuer_name_source":null,"issuer_url":"/issuer/0001106773","owner_cik":"0001360463","owner_name":"Dillaha Larry","owner_display_name":"Dillaha Larry","owner_url":"/insider/0001360463","role":"Officer (EVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Medical Officer","security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":875.0,"shares_display":"875","price_per_share":22.54,"price_display":"22.54","price_state":"stated","total_value":19722.5,"total_display":"19,722.50","total_whole":"19,723","shares_owned_after":75736.0,"shares_owned_after_display":"75,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-20","filed_date":"2008-02-22","scope":"insider"},{"id":3762787,"accession":"0001104659-08-004642","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-08-004642","line_url":"/filing/0001104659-08-004642#line-1","is_derivative":false,"issuer_cik":"0001106773","issuer_name":"SCIELE PHARMA, INC.","issuer_ticker":"SCRX","issuer_name_source":null,"issuer_url":"/issuer/0001106773","owner_cik":"0001360463","owner_name":"Dillaha Larry","owner_display_name":"Dillaha Larry","owner_url":"/insider/0001360463","role":"Officer (EVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Medical Officer","security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":438.0,"shares_display":"438","price_per_share":22.4361,"price_display":"22.44","price_state":"stated","total_value":9827.0118,"total_display":"9,827.01","total_whole":"9,827","shares_owned_after":76611.0,"shares_owned_after_display":"76,611","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-23","filed_date":"2008-01-25","scope":"insider"},{"id":7466803,"accession":"0001104659-07-087928","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-07-087928","line_url":"/filing/0001104659-07-087928#line-1","is_derivative":false,"issuer_cik":"0001106773","issuer_name":"SCIELE PHARMA, INC.","issuer_ticker":"SCRX","issuer_name_source":null,"issuer_url":"/issuer/0001106773","owner_cik":"0001360463","owner_name":"Dillaha Larry","owner_display_name":"Dillaha Larry","owner_url":"/insider/0001360463","role":"Officer (EVP and Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Medical Officer","security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2563.0,"shares_display":"2,563","price_per_share":22.75,"price_display":"22.75","price_state":"stated","total_value":58308.25,"total_display":"58,308.25","total_whole":"58,308","shares_owned_after":77049.0,"shares_owned_after_display":"77,049","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-07","filed_date":"2007-12-10","scope":"insider"},{"id":7466683,"accession":"0001104659-07-074703","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-07-074703","line_url":"/filing/0001104659-07-074703#line-1","is_derivative":false,"issuer_cik":"0001106773","issuer_name":"SCIELE PHARMA, INC.","issuer_ticker":"SCRX","issuer_name_source":null,"issuer_url":"/issuer/0001106773","owner_cik":"0001360463","owner_name":"Dillaha Larry","owner_display_name":"Dillaha Larry","owner_url":"/insider/0001360463","role":"Officer (EVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Medical Officer","security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":28.0,"price_display":"28.00","price_state":"stated","total_value":98000.0,"total_display":"98,000.00","total_whole":"98,000","shares_owned_after":47612.0,"shares_owned_after_display":"47,612","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-10","filed_date":"2007-10-12","scope":"insider"},{"id":7420295,"accession":"0001104659-07-013369","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-07-013369","line_url":"/filing/0001104659-07-013369#line-1","is_derivative":false,"issuer_cik":"0001106773","issuer_name":"SCIELE PHARMA, INC.","issuer_ticker":"SCRX","issuer_name_source":null,"issuer_url":"/issuer/0001106773","owner_cik":"0001360463","owner_name":"Dillaha Larry","owner_display_name":"Dillaha Larry","owner_url":"/insider/0001360463","role":"Officer (EVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Medical Officer","security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1688.0,"shares_display":"1,688","price_per_share":23.89,"price_display":"23.89","price_state":"stated","total_value":40326.32,"total_display":"40,326.32","total_whole":"40,326","shares_owned_after":52312.0,"shares_owned_after_display":"52,312","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-02-21","filed_date":"2007-02-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":17,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":17,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":17},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001516479","name":"Insys Therapeutics, Inc.","url":"/issuer/0001516479","role":"Officer (Chief Medical Officer)","n_filings":1,"first_seen":"2014-03-06","last_seen":"2014-03-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001106773","name":"SCIELE PHARMA, INC.","url":"/issuer/0001106773","role":"Officer (EVP and Chief Medical Officer)","n_filings":7,"first_seen":"2007-02-23","last_seen":"2008-08-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001360463","retrieved_at":"2026-08-26T10:35:05+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}